Cyr61 (CCN1) is a novel target for Zometa (zoledronic acid) in breast cancer bone metastasis.
Year: 2009
Type: conference-abstract
Source: Cancer Research
Institution: Northwestern University
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2093561401